JN.1

FDA Advisers Urge Targeting JN.1 COVID Strain for Fall Vaccine Recipe – Get Ready to Update Your Shots Now!

by

Atlanta, Georgia – As fall approaches, the Centers for Disease Control and Prevention recommend that individuals aged six months and older receive updated COVID-19 and flu shots. The CDC advisory panel’s unanimous vote signals a shift toward treating the SARS-CoV-2 pandemic similarly to other respiratory illnesses like seasonal flu and RSV. In a statement, CDC Director Dr. Mandy Cohen emphasized the importance of vaccination for protecting against respiratory illnesses. Recommendations include routine flu shots targeting …

Read more

KP.3 Variant Dominates U.S.: Experts Push for Targeting JN.1 in Fall Vaccines

by

Atlanta, Georgia – The Centers for Disease Control and Prevention is closely monitoring the new COVID variant KP.3, which is rapidly becoming the dominant strain across the United States. Data from the CDC shows that over a two-week period ending on June 8, 2024, KP.3 accounted for 25% of COVID cases in the country, surpassing the previously prevalent JN.1 variant. This shift in dominance has raised concerns about the potential impact of KP.3 on public …

Read more

“Pivotal” – FDA Advisers Push for JN.1 Variant Targeting in Upcoming Fall COVID Vaccines

by

Atlanta, GA – The Centers for Disease Control and Prevention recently revealed data indicating a surge in the KP.3 variant of COVID-19 cases in the United States. Over a two-week period in May and June, KP.3 became the dominant variant, accounting for 25% of cases, surpassing the previously dominant JN.1 variant at 22.5%. The CDC utilizes the Nowcast data tracker to monitor the prevalence of COVID variants, projecting trends over two-week periods. While the tool …

Read more